Women working in a lab

Featured resource

GHTC 2012 policy report

This fact sheet by the GHTC describes the important role USAID plays in global health research and development, as well as offers policy recommendations for how the agency and Congress can continue to ensure the development of global health tools for low-resourced settings.

Stay up-to-date

EmailOur monthly e-newsletter includes global health research and development features, events, and media coverage, as well as member information.

Twitter

Facebook

YouTube

Annual policy report

GHTC 2012 policy reportEach year, the GHTC releases a policy report that includes recommendations for how US policymakers can continue to advance innovation and save lives around the world. A print summary version (2.7 MB PDF) of the report is also available.

GHTC Member spotlight

R4D

The US Agency for International Development has awarded the CAPRISA 004 tenofovir gel trial the Science and Technology Pioneers Prize. The tenofovir gel is the first microbicide shown to effectively and safely reduce HIV transmission in women. FHI 360 was one of the collaborating partners on the trial.

More about this announcement

More about our members

More about GHTC

Sign up for the GHTC newsletter Follow us

Home | Contact us | Privacy policy | Copyright policy

© 2009–2014, Global Health Technologies Coalition.